-31.0%
MRNA vs RMBS
+142.1%
-173.1%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | RMBS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -12.9% | +10.7% | +1.3% |
| 7D | -12.7% | -19.3% | +6.6% | -7.7% |
| 30D | -20.7% | -28.5% | +7.8% | -13.6% |
| 3M | +46.3% | -28.0% | +74.3% | +58.1% |
| 6M | +305.2% | -50.3% | +355.6% | +371.2% |
| YTD | +561.2% | -27.8% | +589.0% | +553.8% |
| 1Y | +772.1% | -24.0% | +796.1% | +747.0% |
| 3Y | +147.0% | -4.7% | +151.7% | +99.9% |
| All | -31.0% | +142.1% | -173.1% | -69.9% |
Cumulative growth
Daily Returns
Daily percentage return beside RMBS.
Daily Out/Under-Performance
Portfolio return minus RMBS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RMBS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded RMBS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling